What happened. Santander has announced plans to launch an OPA (Oferta Pública de Aquisição — a mandatory public tender offer under Brazilian securities law) to cancel the registration of Santander Brasil on B3 (the São Paulo stock exchange) and take SANB11 units off the market. The Spanish parent wants to buy back all the units held by minority shareholders and convert the Brazilian operation into a wholly private company. For anyone holding SANB11, this is not a market dip that reverses — it is a permanent exit event, and the entire discussion from this point on comes down to a single number: the price Santander will offer.
Few corporate moves in Brazil arrived this telegraphed. SANB11 is a unit — a bundled certificate that packages ordinary and preferred shares of Santander Brasil into a single tradeable instrument on B3. For years, these units carried a structural disadvantage: the Spanish parent never treated the separate Brazilian listing as a showcase for rewarding local shareholders. While Itaú and Bradesco steadily cultivated a retail investor base with regular dividends and JCP (juros sobre capital próprio — a tax-efficient earnings distribution unique to Brazilian law), Santander Brasil was always, first and foremost, an arm of a global group whose primary listing sat in Madrid.
The result was a persistent market discount. The P/VP ratio — price divided by book value per share — for SANB11 spent most of its listed life between 0.7x and 0.9x, meaning the market consistently valued the stock below the bank's accounting net worth. From the parent's perspective, that discount is an invitation: it can buy back something it considers undervalued at a price lower than what the assets are actually worth. The delisting announcement converts that opportunity into action.
How a Brazilian delisting tender offer (OPA) works
Under Brazilian securities regulation (CVM rules), a controlling shareholder that wants to delist a public company must follow a structured process — it cannot simply announce a price and walk away. Three elements protect minority investors:
1. An independent valuation report. The company hires an appraiser — typically an investment bank — to produce a formal valuation of the units. That report must present at least one of three methodologies: net book value (patrimônio líquido), market price average over recent months, and an economic valuation (usually a discounted cash flow or comparable-bank multiples approach). The offer price must be grounded in that report.
2. A minimum acceptance threshold. The delisting cannot proceed unless the tender offer is accepted — or left uncontested — by the equivalent of at least one-third (1/3) of the outstanding minority float, with fewer than 5% of total shares remaining in circulation afterward. In plain terms: if enough minority shareholders reject the price and hold their ground, the delisting fails. That collective veto power is the minority's main tool.
3. The right to demand a second appraisal. Holders representing at least 10% of outstanding shares can call a shareholders' meeting to commission a new, independent valuation if they consider the first one too low. This backstop exists precisely because the appraiser is paid by the same party that wants to buy cheaply — but exercising it requires minorities to coordinate, which is rarely easy.
P/VP, free float, and threshold figures are estimates and regulatory references, not the final offer terms — exact numbers only exist once Santander publishes the official OPA prospectus and appraisal report.
The only question: is the offer price fair?
Everything else is commentary. The decision to accept or reject the tender offer reduces to one comparison: the price Santander offers versus the price that fairly reflects what the bank is actually worth. And here the discount history cuts both ways.
On one hand, the valuation report may anchor on the historical average market price of SANB11 — a price that always baked in the 0.7x–0.9x book discount. If the offer comes in near that average plus a token premium, Santander will effectively be buying back at a discount manufactured by its own failure to court the local market. A 15% premium over the depressed market price might sound generous while still delivering a price 20% below book value.
On the other hand, a large, profitable commercial bank generating double-digit returns on equity is worth more than book value in any honest discounted cash flow model, not less. The tension between a chronically depressed market price and the bank's real earnings power is where the fairness debate lives. Minority shareholders should benchmark the offer against book value and the bank's return on equity — not just against the stock's recent trading range.
The inherent conflict of interest. The party paying for the valuation report is Santander itself — the same party that benefits from a lower price. Independent appraisers are legally required to be objective, but the incentive structure is clear. The minority's safeguards (the 1/3 threshold and the right to a second appraisal) exist precisely to counterbalance this. Read the appraisal report with appropriate skepticism when it is published.
Two doors for shareholders
Once the formal OPA launches, holders of SANB11 face a binary choice.
Accept the offer. You tender your units in the auction and receive the offer price in cash. Clean exit, immediate liquidity — the only question is whether the number is good enough.
Reject the offer. If the OPA closes anyway because the quorum threshold was met by other sellers, you are left holding shares in a private company — no exchange listing, no daily market price, no easy way out. Selling those shares later means finding a private buyer or waiting for another corporate event. Getting stuck in an illiquid closed-company position is a real and concrete risk, not a theoretical one. Rejecting only makes sense as a coordinated move by a large enough group of minorities to either block the OPA outright or force a better price through the second-appraisal mechanism.
The rational framework: the decision is not about whether you like Santander as a bank. It is about whether the price offered exceeds your estimate of fair value. If it does, accepting is straightforward. If it falls clearly short of book value, collective resistance can produce a better number — but collective resistance requires thousands of small investors to act together, and that coordination is always the weakest link.
Risks and the arbitrage angle
The primary risk is a below-fair-value offer anchored in the depressed historical price, compounded by the illiquidity trap for anyone who holds out alone. There is also a timing risk: OPA processes in Brazil typically take several months from announcement to final auction, tying up capital in a position with limited upside.
The opportunity is a classic delisting arbitrage. Once the market prices in the exit, SANB11 tends to converge toward the expected tender price. If the stock still trades at a meaningful discount to the likely offer price, buying that gap is a structured-event trade — not a fundamental thesis on the bank's long-term business. It carries the risk that the offer price comes in lower than expected, or that the OPA is delayed or restructured.
What to watch for
Bottom line: the exit is irreversible — the entire decision is about price, so read the appraisal report before tendering
Treat this as a maturity event, not a market fluctuation. Unlike a price drop that can reverse, the delisting is one-directional. SANB11 will stop trading on B3. The question is not "hold and wait for recovery" — it is "does this offer compensate me fairly for what I own?"
The discount history works against minority holders in negotiations. A bank that always traded at 0.7x–0.9x book gives the parent the narrative to argue the market itself priced it that way. A premium over that depressed market price is not the same as paying fair value. Compare the offer against book value per unit and against the bank's actual return on equity.
Holding out alone is dangerous. Staying in a delisted company's shares without a liquid exit is a real trap. The minority's leverage — the one-third threshold and the second-appraisal right — only works collectively. An individual investor who disagrees with the price but doesn't coordinate will likely end up squeezed.
Key publication to watch: the official OPA prospectus and the appraisal report. Pay close attention to which methodology anchors the offer price (market average vs. discounted cash flow vs. book value), the implied premium over both market price and book value, and whether any significant minority group signals intent to contest. The number in the report — not the announcement — is what determines whether this exit is fair or opportunistic.
